- Home
- BLRX vs LIQT Comparison
BLRX vs LIQT Comparison
Compare BLRX & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- LIQT
- Stock Information
- Founded
- BLRX 2003
- LIQT 2004
- Country
- BLRX Israel
- LIQT Denmark
- Employees
- BLRX N/A
- LIQT N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- LIQT Industrial Machinery/Components
- Sector
- BLRX Health Care
- LIQT Technology
- Exchange
- BLRX Nasdaq
- LIQT Nasdaq
- Market Cap
- BLRX 17.1M
- LIQT 16.1M
- IPO Year
- BLRX 2011
- LIQT N/A
- Fundamental
- Price
- BLRX N/A
- LIQT N/A
- Analyst Decision
- BLRX Strong Buy
- LIQT Strong Buy
- Analyst Count
- BLRX 2
- LIQT 2
- Target Price
- BLRX $19.00
- LIQT $4.80
- AVG Volume (30 Days)
- BLRX 52.2K
- LIQT 13.9K
- Earning Date
- BLRX 11-24-2025
- LIQT 11-13-2025
- Dividend Yield
- BLRX N/A
- LIQT N/A
- EPS Growth
- BLRX N/A
- LIQT N/A
- EPS
- BLRX N/A
- LIQT N/A
- Revenue
- BLRX $17,251,000.00
- LIQT $15,459,242.00
- Revenue This Year
- BLRX N/A
- LIQT $36.89
- Revenue Next Year
- BLRX N/A
- LIQT $16.33
- P/E Ratio
- BLRX N/A
- LIQT N/A
- Revenue Growth
- BLRX 1.19
- LIQT N/A
- 52 Week Low
- BLRX $2.30
- LIQT $1.34
- 52 Week High
- BLRX $22.60
- LIQT $3.11
- Technical
- Relative Strength Index (RSI)
- BLRX 69.50
- LIQT N/A
- Support Level
- BLRX $3.57
- LIQT N/A
- Resistance Level
- BLRX $4.56
- LIQT N/A
- Average True Range (ATR)
- BLRX 0.27
- LIQT 0.00
- MACD
- BLRX 0.08
- LIQT 0.00
- Stochastic Oscillator
- BLRX 87.13
- LIQT 0.00
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.